Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1992 Aug;216(2):117–134. doi: 10.1097/00000658-199208000-00002

Multiple organ failure. Pathophysiology and potential future therapy.

E A Deitch 1
PMCID: PMC1242583  PMID: 1503516

Abstract

Multiple organ failure (MOF) has reached epidemic proportions in most intensive care units and is fast becoming the most common cause of death in the surgical intensive care unit. Furthermore, in spite of the development of successive generations of new and more powerful antibiotics and increasing sophisticated techniques of organ support, our ability to salvage patients once MOF has become established has not appreciably improved over the last two decades. Clearly, new therapeutic strategies aimed at preventing or limiting the development of the physiologic abnormalities that induce organ failure are needed to improve survival in these critically ill patients. Based on our rapidly increasing knowledge of the mechanisms of MOF and the fruits of molecular biology, a number of new therapeutic approaches are in various stages of development. To effectively use these new therapeutic options as they become available, it is necessary to have a clear understanding of the pathophysiology of MOF. Thus, the goals of this review are to integrate the vast amount of new information on the basic biology of MOF and to focus special attention on the potential therapeutic consequences of these recent advances in our understanding of this complex and perplexing syndrome.

Full text

PDF
117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa N., Shinozawa Y., Ishibiki K., Abe O., Yamamoto S., Motegi M., Yoshii H., Sudoh M. Clinical analysis of multiple organ failure in burned patients. Burns Incl Therm Inj. 1987 Apr;13(2):103–109. doi: 10.1016/0305-4179(87)90097-0. [DOI] [PubMed] [Google Scholar]
  2. Alexander H. R., Doherty G. M., Buresh C. M., Venzon D. J., Norton J. A. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med. 1991 Apr 1;173(4):1029–1032. doi: 10.1084/jem.173.4.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alexander H. R., Doherty G. M., Fraker D. L., Block M. I., Swedenborg J. E., Norton J. A. Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res. 1991 May;50(5):421–424. doi: 10.1016/0022-4804(91)90018-h. [DOI] [PubMed] [Google Scholar]
  4. Alexander J. W., Boyce S. T., Babcock G. F., Gianotti L., Peck M. D., Dunn D. L., Pyles T., Childress C. P., Ash S. K. The process of microbial translocation. Ann Surg. 1990 Oct;212(4):496–512. doi: 10.1097/00000658-199010000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Alexander J. W., MacMillan B. G., Stinnett J. D., Ogle C. K., Bozian R. C., Fischer J. E., Oakes J. B., Morris M. J., Krummel R. Beneficial effects of aggressive protein feeding in severely burned children. Ann Surg. 1980;192(4):505–517. doi: 10.1097/00000658-198010000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Allardyce D. B. Incidence of necrotizing pancreatitis and factors related to mortality. Am J Surg. 1987 Sep;154(3):295–299. doi: 10.1016/0002-9610(89)90614-4. [DOI] [PubMed] [Google Scholar]
  7. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  8. Arend W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991 Nov;88(5):1445–1451. doi: 10.1172/JCI115453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ashbaugh D. G., Bigelow D. B., Petty T. L., Levine B. E. Acute respiratory distress in adults. Lancet. 1967 Aug 12;2(7511):319–323. doi: 10.1016/s0140-6736(67)90168-7. [DOI] [PubMed] [Google Scholar]
  10. Astiz M. E., Rackow E. C., Falk J. L., Kaufman B. S., Weil M. H. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med. 1987 Jan;15(1):26–28. doi: 10.1097/00003246-198701000-00005. [DOI] [PubMed] [Google Scholar]
  11. Balkwill F. R., Burke F. The cytokine network. Immunol Today. 1989 Sep;10(9):299–304. doi: 10.1016/0167-5699(89)90085-6. [DOI] [PubMed] [Google Scholar]
  12. Barroso-Aranda J., Schmid-Schönbein G. W., Zweifach B. W., Engler R. L. Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res. 1988 Aug;63(2):437–447. doi: 10.1161/01.res.63.2.437. [DOI] [PubMed] [Google Scholar]
  13. Barton R. W., Rothlein R., Ksiazek J., Kennedy C. The effect of anti-intercellular adhesion molecule-1 on phorbol-ester-induced rabbit lung inflammation. J Immunol. 1989 Aug 15;143(4):1278–1282. [PubMed] [Google Scholar]
  14. Baue A. E. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg. 1975 Jul;110(7):779–781. doi: 10.1001/archsurg.1975.01360130011001. [DOI] [PubMed] [Google Scholar]
  15. Berg R. D., Garlington A. W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979 Feb;23(2):403–411. doi: 10.1128/iai.23.2.403-411.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bihari D., Smithies M., Gimson A., Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med. 1987 Aug 13;317(7):397–403. doi: 10.1056/NEJM198708133170701. [DOI] [PubMed] [Google Scholar]
  17. Billiar T. R., Maddaus M. A., West M. A., Dunn D. L., Simmons R. L. The role of intestinal flora on the interactions between nonparenchymal cells and hepatocytes in coculture. J Surg Res. 1988 Apr;44(4):397–403. doi: 10.1016/0022-4804(88)90182-5. [DOI] [PubMed] [Google Scholar]
  18. Blaisdell F. W. Pathophysiology of the respiratory distress syndrome. Arch Surg. 1974 Jan;108(1):44–49. doi: 10.1001/archsurg.1974.01350250036009. [DOI] [PubMed] [Google Scholar]
  19. Bone L. B., Johnson K. D., Weigelt J., Scheinberg R. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J Bone Joint Surg Am. 1989 Mar;71(3):336–340. [PubMed] [Google Scholar]
  20. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987 Sep 10;317(11):653–658. doi: 10.1056/NEJM198709103171101. [DOI] [PubMed] [Google Scholar]
  21. Bone R. C., Fisher C. J., Jr, Clemmer T. P., Slotman G. J., Metz C. A., Balk R. A. Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med. 1989 May;17(5):389–393. [PubMed] [Google Scholar]
  22. Bone R. C. Let's agree on terminology: definitions of sepsis. Crit Care Med. 1991 Jul;19(7):973–976. doi: 10.1097/00003246-199107000-00024. [DOI] [PubMed] [Google Scholar]
  23. Border J. R., Hassett J., LaDuca J., Seibel R., Steinberg S., Mills B., Losi P., Border D. The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg. 1987 Oct;206(4):427–448. doi: 10.1097/00000658-198710000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Border J. R. Hypothesis: sepsis, multiple systems organ failure, and the macrophage. Arch Surg. 1988 Mar;123(3):285–286. doi: 10.1001/archsurg.1988.01400270019001. [DOI] [PubMed] [Google Scholar]
  25. Bosson S., Kuenzig M., Schwartz S. I. Verapamil improves cardiac function and increases survival in canine E. coli endotoxin shock. Circ Shock. 1985;16(3):307–316. [PubMed] [Google Scholar]
  26. Bunt T. J. Non-directed relaparotomy for intra-abdominal sepsis. A futile procedure. Am Surg. 1986 Jun;52(6):294–298. [PubMed] [Google Scholar]
  27. Cain S. M., Curtis S. E. Experimental models of pathologic oxygen supply dependency. Crit Care Med. 1991 May;19(5):603–612. doi: 10.1097/00003246-199105000-00006. [DOI] [PubMed] [Google Scholar]
  28. Cannon J. G., Tompkins R. G., Gelfand J. A., Michie H. R., Stanford G. G., van der Meer J. W., Endres S., Lonnemann G., Corsetti J., Chernow B. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 1990 Jan;161(1):79–84. doi: 10.1093/infdis/161.1.79. [DOI] [PubMed] [Google Scholar]
  29. Carlos T. M., Harlan J. M. Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev. 1990 Apr;114:5–28. doi: 10.1111/j.1600-065x.1990.tb00559.x. [DOI] [PubMed] [Google Scholar]
  30. Cerra F. B. Hypermetabolism, organ failure, and metabolic support. Surgery. 1987 Jan;101(1):1–14. [PubMed] [Google Scholar]
  31. Cerra F. B., McPherson J. P., Konstantinides F. N., Konstantinides N. N., Teasley K. M. Enteral nutrition does not prevent multiple organ failure syndrome (MOFS) after sepsis. Surgery. 1988 Oct;104(4):727–733. [PubMed] [Google Scholar]
  32. Cerra F. B. Nutrient modulation of inflammatory and immune function. Am J Surg. 1991 Feb;161(2):230–234. doi: 10.1016/0002-9610(91)91136-7. [DOI] [PubMed] [Google Scholar]
  33. Chiu C. J., McArdle A. H., Brown R., Scott H. J., Gurd F. N. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970 Oct;101(4):478–483. doi: 10.1001/archsurg.1970.01340280030009. [DOI] [PubMed] [Google Scholar]
  34. Cioffi W. G., Jr, Burleson D. G., Jordan B. S., Becker W. K., McManus W. F., Mason A. D., Jr, Pruitt B. A., Jr Effects of granulocyte-macrophage colony-stimulating factor in burn patients. Arch Surg. 1991 Jan;126(1):74–79. doi: 10.1001/archsurg.1991.01410250080013. [DOI] [PubMed] [Google Scholar]
  35. Civetta J. M., Hudson-Civetta J. A., Nelson L. D. Evaluation of APACHE II for cost containment and quality assurance. Ann Surg. 1990 Sep;212(3):266–276. doi: 10.1097/00000658-199009000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Cochrane C. G. The enhancement of inflammatory injury. Am Rev Respir Dis. 1987 Jul;136(1):1–2. doi: 10.1164/ajrccm/136.1.1. [DOI] [PubMed] [Google Scholar]
  37. Crump J. M., Duncan D. A., Wears R. Analysis of multiple organ system failure in trauma and nontrauma patients. Am Surg. 1988 Dec;54(12):702–708. [PubMed] [Google Scholar]
  38. Damas P., Reuter A., Gysen P., Demonty J., Lamy M., Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med. 1989 Oct;17(10):975–978. doi: 10.1097/00003246-198910000-00001. [DOI] [PubMed] [Google Scholar]
  39. DeCamp M. M., Demling R. H. Posttraumatic multisystem organ failure. JAMA. 1988 Jul 22;260(4):530–534. [PubMed] [Google Scholar]
  40. DeMaria A., Carven D. E., Heffernan J. J., McIntosh T. K., Grindlinger G. A., McCabe W. R. Naloxone versus placebo in treatment of septic shock. Lancet. 1985 Jun 15;1(8442):1363–1365. doi: 10.1016/s0140-6736(85)91787-8. [DOI] [PubMed] [Google Scholar]
  41. Debets J. M., Kampmeijer R., van der Linden M. P., Buurman W. A., van der Linden C. J. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989 Jun;17(6):489–494. doi: 10.1097/00003246-198906000-00001. [DOI] [PubMed] [Google Scholar]
  42. Deitch E. A. Bacterial translocation of the gut flora. J Trauma. 1990 Dec;30(12 Suppl):S184–S189. doi: 10.1097/00005373-199012001-00037. [DOI] [PubMed] [Google Scholar]
  43. Deitch E. A., Bridges W., Baker J., Ma J. W., Ma L., Grisham M. B., Granger D. N., Specian R. D., Berg R. Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery. 1988 Aug;104(2):191–198. [PubMed] [Google Scholar]
  44. Deitch E. A. Intestinal permeability is increased in burn patients shortly after injury. Surgery. 1990 Apr;107(4):411–416. [PubMed] [Google Scholar]
  45. Deitch E. A., Ma L., Ma W. J., Grisham M. B., Granger D. N., Specian R. D., Berg R. D. Inhibition of endotoxin-induced bacterial translocation in mice. J Clin Invest. 1989 Jul;84(1):36–42. doi: 10.1172/JCI114164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Deitch E. A., Maejima K., Berg R. Effect of oral antibiotics and bacterial overgrowth on the translocation of the GI tract microflora in burned rats. J Trauma. 1985 May;25(5):385–392. doi: 10.1097/00005373-198505000-00002. [DOI] [PubMed] [Google Scholar]
  47. Deitch E. A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990 Mar;125(3):403–404. doi: 10.1001/archsurg.1990.01410150125024. [DOI] [PubMed] [Google Scholar]
  48. Dellinger E. P. Use of scoring systems to assess patients with surgical sepsis. Surg Clin North Am. 1988 Feb;68(1):123–145. doi: 10.1016/s0039-6109(16)44436-1. [DOI] [PubMed] [Google Scholar]
  49. Driks M. R., Craven D. E., Celli B. R., Manning M., Burke R. A., Garvin G. M., Kunches L. M., Farber H. W., Wedel S. A., McCabe W. R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. doi: 10.1056/NEJM198711263172204. [DOI] [PubMed] [Google Scholar]
  50. Eiseman B., Beart R., Norton L. Multiple organ failure. Surg Gynecol Obstet. 1977 Mar;144(3):323–326. [PubMed] [Google Scholar]
  51. Evans D. A., Jacobs D. O., Revhaug A., Wilmore D. W. The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg. 1989 Mar;209(3):312–321. doi: 10.1097/00000658-198903000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Evers B. M., Izukura M., Townsend C. M., Jr, Uchida T., Thompson J. C. Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet. Ann Surg. 1990 May;211(5):630–638. [PMC free article] [PubMed] [Google Scholar]
  53. Exley A. R., Cohen J., Buurman W., Owen R., Hanson G., Lumley J., Aulakh J. M., Bodmer M., Riddell A., Stephens S. Monoclonal antibody to TNF in severe septic shock. Lancet. 1990 May 26;335(8700):1275–1277. doi: 10.1016/0140-6736(90)91337-a. [DOI] [PubMed] [Google Scholar]
  54. Faist E., Baue A. E., Dittmer H., Heberer G. Multiple organ failure in polytrauma patients. J Trauma. 1983 Sep;23(9):775–787. doi: 10.1097/00005373-198309000-00002. [DOI] [PubMed] [Google Scholar]
  55. Faist E., Markewitz A., Fuchs D., Lang S., Zarius S., Schildberg F. W., Wachter H., Reichart B. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Ann Surg. 1991 Sep;214(3):264–275. doi: 10.1097/00000658-199109000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Faist E., Mewes A., Strasser T., Walz A., Alkan S., Baker C., Ertel W., Heberer G. Alteration of monocyte function following major injury. Arch Surg. 1988 Mar;123(3):287–292. doi: 10.1001/archsurg.1988.01400270021002. [DOI] [PubMed] [Google Scholar]
  57. Fasano M. B., Cousart S., Neal S., McCall C. E. Increased expression of the interleukin 1 receptor on blood neutrophils of humans with the sepsis syndrome. J Clin Invest. 1991 Nov;88(5):1452–1459. doi: 10.1172/JCI115454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Fletcher J. R., DiSimone A. G., Earnest M. A. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia. Ann Surg. 1990 Mar;211(3):312–316. [PMC free article] [PubMed] [Google Scholar]
  59. Fong Y., Moldawer L. L., Shires G. T., Lowry S. F. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet. 1990 Apr;170(4):363–378. [PubMed] [Google Scholar]
  60. Fong Y., Tracey K. J., Moldawer L. L., Hesse D. G., Manogue K. B., Kenney J. S., Lee A. T., Kuo G. C., Allison A. C., Lowry S. F. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med. 1989 Nov 1;170(5):1627–1633. doi: 10.1084/jem.170.5.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Fry D. E., Pearlstein L., Fulton R. L., Polk H. C., Jr Multiple system organ failure. The role of uncontrolled infection. Arch Surg. 1980 Feb;115(2):136–140. doi: 10.1001/archsurg.1980.01380020006003. [DOI] [PubMed] [Google Scholar]
  62. Garrison R. N., Fry D. E., Berberich S., Polk H. C., Jr Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg. 1982 Jul;196(1):43–47. doi: 10.1097/00000658-198207000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Girardin E., Grau G. E., Dayer J. M., Roux-Lombard P., Lambert P. H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med. 1988 Aug 18;319(7):397–400. doi: 10.1056/NEJM198808183190703. [DOI] [PubMed] [Google Scholar]
  64. Goris R. J., Gimbrère J. S., van Niekerk J. L., Schoots F. J., Booy L. H. Early osteosynthesis and prophylactic mechanical ventilation in the multitrauma patient. J Trauma. 1982 Nov;22(11):895–903. doi: 10.1097/00005373-198211000-00002. [DOI] [PubMed] [Google Scholar]
  65. Goris R. J., te Boekhorst T. P., Nuytinck J. K., Gimbrère J. S. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg. 1985 Oct;120(10):1109–1115. doi: 10.1001/archsurg.1985.01390340007001. [DOI] [PubMed] [Google Scholar]
  66. Greenman R. L., Schein R. M., Martin M. A., Wenzel R. P., MacIntyre N. R., Emmanuel G., Chmel H., Kohler R. B., McCarthy M., Plouffe J. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. 1991 Aug 28;266(8):1097–1102. [PubMed] [Google Scholar]
  67. Guo Y., Dickerson C., Chrest F. J., Adler W. H., Munster A. M., Winchurch R. A. Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol. 1990 Mar;54(3):361–371. doi: 10.1016/0090-1229(90)90050-z. [DOI] [PubMed] [Google Scholar]
  68. Guthrie L. A., McPhail L. C., Henson P. M., Johnston R. B., Jr Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med. 1984 Dec 1;160(6):1656–1671. doi: 10.1084/jem.160.6.1656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Hack C. E., De Groot E. R., Felt-Bersma R. J., Nuijens J. H., Strack Van Schijndel R. J., Eerenberg-Belmer A. J., Thijs L. G., Aarden L. A. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989 Oct;74(5):1704–1710. [PubMed] [Google Scholar]
  70. Haupt M. T., Jastremski M. S., Clemmer T. P., Metz C. A., Goris G. B. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med. 1991 Nov;19(11):1339–1347. doi: 10.1097/00003246-199111000-00006. [DOI] [PubMed] [Google Scholar]
  71. Helfgott D. C., Tatter S. B., Santhanam U., Clarick R. H., Bhardwaj N., May L. T., Sehgal P. B. Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol. 1989 Feb 1;142(3):948–953. [PubMed] [Google Scholar]
  72. Henao F. J., Daes J. E., Dennis R. J. Risk factors for multiorgan failure: a case-control study. J Trauma. 1991 Jan;31(1):74–80. doi: 10.1097/00005373-199101000-00014. [DOI] [PubMed] [Google Scholar]
  73. Hernandez L. A., Grisham M. B., Twohig B., Arfors K. E., Harlan J. M., Granger D. N. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol. 1987 Sep;253(3 Pt 2):H699–H703. doi: 10.1152/ajpheart.1987.253.3.H699. [DOI] [PubMed] [Google Scholar]
  74. Hesse D. G., Tracey K. J., Fong Y., Manogue K. R., Palladino M. A., Jr, Cerami A., Shires G. T., Lowry S. F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 1988 Feb;166(2):147–153. [PubMed] [Google Scholar]
  75. Hesse D. G., Tracey K. J., Fong Y., Manogue K. R., Palladino M. A., Jr, Cerami A., Shires G. T., Lowry S. F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet. 1988 Feb;166(2):147–153. [PubMed] [Google Scholar]
  76. Hinsdale J. G., Jaffe B. M. Re-operation for intra-abdominal sepsis. Indications and results in modern critical care setting. Ann Surg. 1984 Jan;199(1):31–36. doi: 10.1097/00000658-198401000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Hinshaw L. B., Tekamp-Olson P., Chang A. C., Lee P. A., Taylor F. B., Jr, Murray C. K., Peer G. T., Emerson T. E., Jr, Passey R. B., Kuo G. C. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circ Shock. 1990 Mar;30(3):279–292. [PubMed] [Google Scholar]
  78. Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979 Jul 5;301(1):5–8. doi: 10.1056/NEJM197907053010102. [DOI] [PubMed] [Google Scholar]
  79. Jacobs D. O., Evans D. A., Mealy K., O'Dwyer S. T., Smith R. J., Wilmore D. W. Combined effects of glutamine and epidermal growth factor on the rat intestine. Surgery. 1988 Aug;104(2):358–364. [PubMed] [Google Scholar]
  80. Jarrett F., Balish E., Moylan J. A., Ellerbe S. Clinical experience with prophylactic antibiotic bowel suppression in burn patients. Surgery. 1978 May;83(5):523–527. [PubMed] [Google Scholar]
  81. Johnson K. D., Cadambi A., Seibert G. B. Incidence of adult respiratory distress syndrome in patients with multiple musculoskeletal injuries: effect of early operative stabilization of fractures. J Trauma. 1985 May;25(5):375–384. doi: 10.1097/00005373-198505000-00001. [DOI] [PubMed] [Google Scholar]
  82. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. Prognosis in acute organ-system failure. Ann Surg. 1985 Dec;202(6):685–693. doi: 10.1097/00000658-198512000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Kudsk K. A., Stone J. M., Carpenter G., Sheldon G. F. Enteral and parenteral feeding influences mortality after hemoglobin-E. coli peritonitis in normal rats. J Trauma. 1983 Jul;23(7):605–609. doi: 10.1097/00005373-198307000-00010. [DOI] [PubMed] [Google Scholar]
  84. Lehy T., Puccio F., Chariot J., Labeille D. Stimulating effect of bombesin on the growth of gastrointestinal tract and pancreas in suckling rats. Gastroenterology. 1986 Jun;90(6):1942–1949. doi: 10.1016/0016-5085(86)90265-9. [DOI] [PubMed] [Google Scholar]
  85. Levine B., Kalman J., Mayer L., Fillit H. M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241. doi: 10.1056/NEJM199007263230405. [DOI] [PubMed] [Google Scholar]
  86. Livingston D. H., Malangoni M. A. Interferon-gamma restores immune competence after hemorrhagic shock. J Surg Res. 1988 Jul;45(1):37–43. doi: 10.1016/0022-4804(88)90018-2. [DOI] [PubMed] [Google Scholar]
  87. Ma L., Ma J. W., Deitch E. A., Specian R. D., Berg R. D. Genetic susceptibility to mucosal damage leads to bacterial translocation in a murine burn model. J Trauma. 1989 Sep;29(9):1245–1251. doi: 10.1097/00005373-198909000-00010. [DOI] [PubMed] [Google Scholar]
  88. Mainous M. R., Tso P., Berg R. D., Deitch E. A. Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation. Arch Surg. 1991 Jan;126(1):33–37. doi: 10.1001/archsurg.1991.01410250037005. [DOI] [PubMed] [Google Scholar]
  89. Mansberger A. R., Doran J. E., Treat R., Hawkins M., May J. R., Callaway B. D., Horowitz M., Horowitz B., Shulman R. The influence of fibronectin administration on the incidence of sepsis and septic mortality in severely injured patients. The Medical College of Georgia Fibronectin Research Group. Ann Surg. 1989 Sep;210(3):297–307. doi: 10.1097/00000658-198909000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Manship L., McMillin R. D., Brown J. J. The influence of sepsis and multisystem and organ failure on mortality in the surgical intensive care unit. Am Surg. 1984 Feb;50(2):94–101. [PubMed] [Google Scholar]
  91. Marano M. A., Fong Y., Moldawer L. L., Wei H., Calvano S. E., Tracey K. J., Barie P. S., Manogue K., Cerami A., Shires G. T. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet. 1990 Jan;170(1):32–38. [PubMed] [Google Scholar]
  92. Marshall W. G., Jr, Dimick A. R. The natural history of major burns with multiple subsystem failure. J Trauma. 1983 Feb;23(2):102–105. doi: 10.1097/00005373-198302000-00005. [DOI] [PubMed] [Google Scholar]
  93. Maury C. P., Salo E., Pelkonen P. Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med. 1988 Dec 22;319(25):1670–1671. doi: 10.1056/NEJM198812223192515. [DOI] [PubMed] [Google Scholar]
  94. Maury C. P., Teppo A. M. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med. 1987 Oct 1;166(4):1132–1137. doi: 10.1084/jem.166.4.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. McCartney A. C., Banks J. G., Clements G. B., Sleigh J. D., Tehrani M., Ledingham I. M. Endotoxaemia in septic shock: clinical and post mortem correlations. Intensive Care Med. 1983;9(3):117–122. doi: 10.1007/BF01772577. [DOI] [PubMed] [Google Scholar]
  96. McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985 Jan 17;312(3):159–163. doi: 10.1056/NEJM198501173120305. [DOI] [PubMed] [Google Scholar]
  97. McCord J. M. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc. 1987 May 15;46(7):2402–2406. [PubMed] [Google Scholar]
  98. McDonald W. S., Sharp C. W., Jr, Deitch E. A. Immediate enteral feeding in burn patients is safe and effective. Ann Surg. 1991 Feb;213(2):177–183. doi: 10.1097/00000658-199102000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Michie H. R., Manogue K. R., Spriggs D. R., Revhaug A., O'Dwyer S., Dinarello C. A., Cerami A., Wolff S. M., Wilmore D. W. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988 Jun 9;318(23):1481–1486. doi: 10.1056/NEJM198806093182301. [DOI] [PubMed] [Google Scholar]
  100. Michie H. R., Spriggs D. R., Manogue K. R., Sherman M. L., Revhaug A., O'Dwyer S. T., Arthur K., Dinarello C. A., Cerami A., Wolff S. M. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988 Aug;104(2):280–286. [PubMed] [Google Scholar]
  101. Mileski W. J., Winn R. K., Vedder N. B., Pohlman T. H., Harlan J. M., Rice C. L. Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery. 1990 Aug;108(2):206–212. [PubMed] [Google Scholar]
  102. Mochizuki H., Trocki O., Dominioni L., Brackett K. A., Joffe S. N., Alexander J. W. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg. 1984 Sep;200(3):297–310. doi: 10.1097/00000658-198409000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  104. Moore F. A., Moore E. E., Jones T. N., McCroskey B. L., Peterson V. M. TEN versus TPN following major abdominal trauma--reduced septic morbidity. J Trauma. 1989 Jul;29(7):916–923. doi: 10.1097/00005373-198907000-00003. [DOI] [PubMed] [Google Scholar]
  105. Moore F. A., Moore E. E., Poggetti R., McAnena O. J., Peterson V. M., Abernathy C. M., Parsons P. E. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma. 1991 May;31(5):629–638. doi: 10.1097/00005373-199105000-00006. [DOI] [PubMed] [Google Scholar]
  106. Moore F. D., Jr, Moss N. A., Revhaug A., Wilmore D., Mannick J. A., Rodrick M. L. A single dose of endotoxin activates neutrophils without activating complement. Surgery. 1987 Aug;102(2):200–205. [PubMed] [Google Scholar]
  107. Morrison D. C., Ryan J. L. Endotoxins and disease mechanisms. Annu Rev Med. 1987;38:417–432. doi: 10.1146/annurev.me.38.020187.002221. [DOI] [PubMed] [Google Scholar]
  108. Mulligan M. S., Varani J., Dame M. K., Lane C. L., Smith C. W., Anderson D. C., Ward P. A. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest. 1991 Oct;88(4):1396–1406. doi: 10.1172/JCI115446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Nijsten M. W., Hack C. E., Helle M., ten Duis H. J., Klasen H. J., Aarden L. A. Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients. Surgery. 1991 Jun;109(6):761–767. [PubMed] [Google Scholar]
  110. Norton L. W. Does drainage of intraabdominal pus reverse multiple organ failure? Am J Surg. 1985 Mar;149(3):347–350. doi: 10.1016/s0002-9610(85)80105-7. [DOI] [PubMed] [Google Scholar]
  111. Nuytinck H. K., Offermans X. J., Kubat K., Goris J. A. Whole-body inflammation in trauma patients. An autopsy study. Arch Surg. 1988 Dec;123(12):1519–1524. doi: 10.1001/archsurg.1988.01400360089016. [DOI] [PubMed] [Google Scholar]
  112. O'Dwyer S. T., Michie H. R., Ziegler T. R., Revhaug A., Smith R. J., Wilmore D. W. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg. 1988 Dec;123(12):1459–1464. doi: 10.1001/archsurg.1988.01400360029003. [DOI] [PubMed] [Google Scholar]
  113. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990 Jul 13;62(1):3–6. doi: 10.1016/0092-8674(90)90230-c. [DOI] [PubMed] [Google Scholar]
  114. Pober J. S., Cotran R. S. Cytokines and endothelial cell biology. Physiol Rev. 1990 Apr;70(2):427–451. doi: 10.1152/physrev.1990.70.2.427. [DOI] [PubMed] [Google Scholar]
  115. Pober J. S., Cotran R. S. The role of endothelial cells in inflammation. Transplantation. 1990 Oct;50(4):537–544. doi: 10.1097/00007890-199010000-00001. [DOI] [PubMed] [Google Scholar]
  116. Pober J. S. Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol. 1988 Dec;133(3):426–433. [PMC free article] [PubMed] [Google Scholar]
  117. Polk H. C., Jr, Shields C. L. Remote organ failure: a valid sign of occult intra-abdominal infection. Surgery. 1977 Mar;81(3):310–313. [PubMed] [Google Scholar]
  118. Reidy J. J., Ramsay G. Clinical trials of selective decontamination of the digestive tract: review. Crit Care Med. 1990 Dec;18(12):1449–1456. doi: 10.1097/00003246-199012000-00028. [DOI] [PubMed] [Google Scholar]
  119. Reilly P. M., Schiller H. J., Bulkley G. B. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg. 1991 Apr;161(4):488–503. doi: 10.1016/0002-9610(91)91120-8. [DOI] [PubMed] [Google Scholar]
  120. Revhaug A., Michie H. R., Manson J. M., Watters J. M., Dinarello C. A., Wolff S. M., Wilmore D. W. Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans. Arch Surg. 1988 Feb;123(2):162–170. doi: 10.1001/archsurg.1988.01400260042004. [DOI] [PubMed] [Google Scholar]
  121. Rolandelli R. H., Koruda M. J., Settle R. G., Rombeau J. L. Effects of intraluminal infusion of short-chain fatty acids on the healing of colonic anastomosis in the rat. Surgery. 1986 Aug;100(2):198–204. [PubMed] [Google Scholar]
  122. Rush B. F., Jr Irreversibility in hemorrhagic shock is caused by sepsis. Am Surg. 1989 Apr;55(4):204–208. [PubMed] [Google Scholar]
  123. Rush B. F., Jr, Sori A. J., Murphy T. F., Smith S., Flanagan J. J., Jr, Machiedo G. W. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg. 1988 May;207(5):549–554. doi: 10.1097/00000658-198805000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Seibel R., LaDuca J., Hassett J. M., Babikian G., Mills B., Border D. O., Border J. R. Blunt multiple trauma (ISS 36), femur traction, and the pulmonary failure-septic state. Ann Surg. 1985 Sep;202(3):283–295. doi: 10.1097/00000658-198509000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Shenep J. L., Flynn P. M., Barrett F. F., Stidham G. L., Westenkirchner D. F. Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis. 1988 Mar;157(3):565–568. doi: 10.1093/infdis/157.3.565. [DOI] [PubMed] [Google Scholar]
  126. Shenep J. L., Mogan K. A. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. J Infect Dis. 1984 Sep;150(3):380–388. doi: 10.1093/infdis/150.3.380. [DOI] [PubMed] [Google Scholar]
  127. Shenkin A., Fraser W. D., Series J., Winstanley F. P., McCartney A. C., Burns H. J., Van Damme J. The serum interleukin 6 response to elective surgery. Lymphokine Res. 1989 Summer;8(2):123–127. [PubMed] [Google Scholar]
  128. Sheppard B. C., Fraker D. L., Norton J. A. Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery. 1989 Aug;106(2):156–162. [PubMed] [Google Scholar]
  129. Shires G. T., Cunningham J. N., Backer C. R., Reeder S. F., Illner H., Wagner I. Y., Maher J. Alterations in cellular membrane function during hemorrhagic shock in primates. Ann Surg. 1972 Sep;176(3):288–295. doi: 10.1097/00000658-197209000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Shoemaker W. C., Appel P. L., Kram H. B., Waxman K., Lee T. S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988 Dec;94(6):1176–1186. doi: 10.1378/chest.94.6.1176. [DOI] [PubMed] [Google Scholar]
  131. Shoemaker W. C., Kram H. B., Appel P. L., Fleming A. W. The efficacy of central venous and pulmonary artery catheters and therapy based upon them in reducing mortality and morbidity. Arch Surg. 1990 Oct;125(10):1332–1338. doi: 10.1001/archsurg.1990.01410220116016. [DOI] [PubMed] [Google Scholar]
  132. Sibbald W. J., Marshall J., Christou N., Girotti M., McCormack D., Rostein O., Martin C., Meakins J. "Sepsis"--clarity of existing terminology ... or more confusion? Crit Care Med. 1991 Aug;19(8):996–998. doi: 10.1097/00003246-199108000-00001. [DOI] [PubMed] [Google Scholar]
  133. Souba W. W., Smith R. J., Wilmore D. W. Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr. 1985 Sep-Oct;9(5):608–617. doi: 10.1177/0148607185009005608. [DOI] [PubMed] [Google Scholar]
  134. Spaeth G., Berg R. D., Specian R. D., Deitch E. A. Food without fiber promotes bacterial translocation from the gut. Surgery. 1990 Aug;108(2):240–247. [PubMed] [Google Scholar]
  135. Sprung C. L. Definitions of sepsis--have we reached a consensus? Crit Care Med. 1991 Jul;19(7):849–851. [PubMed] [Google Scholar]
  136. Starnes H. F., Jr, Warren R. S., Jeevanandam M., Gabrilove J. L., Larchian W., Oettgen H. F., Brennan M. F. Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest. 1988 Oct;82(4):1321–1325. doi: 10.1172/JCI113733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Stoutenbeek C. P., van Saene H. K., Miranda D. R., Zandstra D. F. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med. 1984;10(4):185–192. doi: 10.1007/BF00259435. [DOI] [PubMed] [Google Scholar]
  138. Sullivan B. J., Swallow C. J., Girotti M. J., Rotstein O. D. Bacterial translocation induces procoagulant activity in tissue macrophages. A potential mechanism for end-organ dysfunction. Arch Surg. 1991 May;126(5):586–590. doi: 10.1001/archsurg.1991.01410290062013. [DOI] [PubMed] [Google Scholar]
  139. Sun X. M., Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest. 1988 May;81(5):1328–1331. doi: 10.1172/JCI113459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Tilney N. L., Bailey G. L., Morgan A. P. Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg. 1973 Aug;178(2):117–122. doi: 10.1097/00000658-197308000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Townsend M. C., Hampton W. W., Haybron D. M., Schirmer W. J., Fry D. E. Effective organ blood flow and bioenergy status in murine peritonitis. Surgery. 1986 Aug;100(2):205–213. [PubMed] [Google Scholar]
  142. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987 Dec 17;330(6149):662–664. doi: 10.1038/330662a0. [DOI] [PubMed] [Google Scholar]
  143. Tracey K. J. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock. 1991 Oct;35(2):123–128. [PubMed] [Google Scholar]
  144. Van Oers M. H., Van der Heyden A. A., Aarden L. A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol. 1988 Feb;71(2):314–319. [PMC free article] [PubMed] [Google Scholar]
  145. Vane J. R., Anggård E. E., Botting R. M. Regulatory functions of the vascular endothelium. N Engl J Med. 1990 Jul 5;323(1):27–36. doi: 10.1056/NEJM199007053230106. [DOI] [PubMed] [Google Scholar]
  146. Vedder N. B., Winn R. K., Rice C. L., Chi E. Y., Arfors K. E., Harlan J. M. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest. 1988 Mar;81(3):939–944. doi: 10.1172/JCI113407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Waage A., Halstensen A., Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987 Feb 14;1(8529):355–357. doi: 10.1016/s0140-6736(87)91728-4. [DOI] [PubMed] [Google Scholar]
  149. Watters J. M., Bessey P. Q., Dinarello C. A., Wolff S. M., Wilmore D. W. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg. 1986 Feb;121(2):179–190. doi: 10.1001/archsurg.1986.01400020065008. [DOI] [PubMed] [Google Scholar]
  150. Wells C. L., Rotstein O. D., Pruett T. L., Simmons R. L. Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg. 1986 Jan;121(1):102–107. doi: 10.1001/archsurg.1986.01400010116016. [DOI] [PubMed] [Google Scholar]
  151. West M. A., Keller G. A., Cerra F. B., Simmons R. L. Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infect Immun. 1985 Sep;49(3):563–570. doi: 10.1128/iai.49.3.563-570.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Wilmore D. W. Catabolic illness. Strategies for enhancing recovery. N Engl J Med. 1991 Sep 5;325(10):695–702. doi: 10.1056/NEJM199109053251005. [DOI] [PubMed] [Google Scholar]
  153. Wilmore D. W., Smith R. J., O'Dwyer S. T., Jacobs D. O., Ziegler T. R., Wang X. D. The gut: a central organ after surgical stress. Surgery. 1988 Nov;104(5):917–923. [PubMed] [Google Scholar]
  154. Wolf Y. G., Cotev S., Perel A., Manny J. Dependence of oxygen consumption on cardiac output in sepsis. Crit Care Med. 1987 Mar;15(3):198–203. doi: 10.1097/00003246-198703000-00003. [DOI] [PubMed] [Google Scholar]
  155. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]
  156. Ziegler T. R., Smith R. J., O'Dwyer S. T., Demling R. H., Wilmore D. W. Increased intestinal permeability associated with infection in burn patients. Arch Surg. 1988 Nov;123(11):1313–1319. doi: 10.1001/archsurg.1988.01400350027003. [DOI] [PubMed] [Google Scholar]
  157. de Groote M. A., Martin M. A., Densen P., Pfaller M. A., Wenzel R. P. Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. JAMA. 1989 Jul 14;262(2):249–251. doi: 10.1001/jama.262.2.249. [DOI] [PubMed] [Google Scholar]
  158. van der Waaij D., Berghuis-de Vries J. M., Lekkerkerk Lekkerkerk-v Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971 Sep;69(3):405–411. doi: 10.1017/s0022172400021653. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES